USA TODAYUSA TODAY

FDA approves treatment that delays type 1 diabetes. It could be 'game changing'

View descriptionShare

A vial of TZIELD costs nearly $14,000, a notable price given the escalating cost of lifesaving insulin for people with diabetes.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

USA TODAY

Get the latest news, sports, entertainment, money and tech stories from USA TODAY through your voice 
Social links
Follow podcast
Recent clips
Browse 18,027 clip(s)